Objective  To understand the current status of knowledge-attitude-practice (KAP) regarding risk of medication safety behavior among cancer patients in western Yunnan and the related influencing factors, and to provide a basis for conducting rational medication education.

Methods  Using an approximate random sampling method, a KAP survey on medication safety behavior was conducted among inpatients and outpatients with cancer (aged over 18 years) in multiple hospitals in western Yunnan through online and offline questionnaires. Multiple linear regression analysis was used to explore the impact of different characteristics of the research objects on the KAP scores concerning medication knowledge, behavior, and attitude.

Results  A total of 512 valid questionnaires were collected. The average scores of medication knowledge, attitude, and behavior among cancer patients were (82.53±23.07), (41.98±8.64), and (67.88±10.08), respectively. Medication knowledge and behavior were at a good level, while medication attitude was at a qualified level. The multiple linear regression results showed that the educational level was a significant influencing factor of the medication knowledge and attitude scores (P<0.001).

Conclusion  The overall medication safety among cancer patients in western Yunnan is in a good state, however, there is a need for improvement in medication attitudes. Educational level is the main factor affecting medication safety risk. Pharmacy services should be focused on cancer patients with lower educational levels to enhance their medication safety.

1.王宝华. 中国恶性肿瘤及危险因素流行病学调查回顾与展望[J]. 环境卫生学杂志, 2024, 14(10): 793-801. [Wang BH. Retrospect and prospect on epidemiological investigation of malignant tumors and risk factors in China[J]. Journal of Environmental Hygiene, 2024, 14(10): 793-801.] DOI: 10.13421/j.cnki.hjwsxzz.2024.10.001.

2.杨璧榕, 余龙涛, 李震萍, 等. 2012—2019年云南省肿瘤登记地区恶性肿瘤的发病与死亡趋势分析[J]. 中国肿瘤, 2024, 33(2): 125-133. [Yang BR, Yu LT, Li ZP, et al. Trends of cancer incidence and mortality in cancer registration areas of Yunnan province from 2012 to 2019[J]. China Cancer, 2024, 33(2): 125-133.] DOI: 10.11735/j.issn.1004-0242.2024.02.A007.

3.王建宇, 吴苏道毕力格, 李秀丽. 少数民族地区居民用药风险调查及影响因素研究[J]. 赤峰学院学报（自然科学版）, 2023, 39(1): 34-39. [Wang JY, Wu SDBLG, Li XL. Investigation on medication risks and influencing factors of residents in minority areas[J]. Journal of Chifeng University, 2023, 39(1): 34-39.] DOI: 10.13398/j.cnki.issn1673-260x.2023.01.003.

4.张文平, 杨钰敏, 宗思凡, 等. 云南白族公众对药品不良反应认知度的调研[J]. 药学研究, 2019, 38(5): 307-310. [Zhang WP, Yang YM, Zong SF, et al. Survey of Bai public's cognition of adverse drug reaction in Yunnan Province[J]. Journal of Pharmaceutical Research, 2019, 38(5): 307-310.] DOI: 10.13506/j.cnki.jpr.2019.05.015.

5.Watanabe JH, McInnisT, Hirsch JD. Cost of prescription drug-related morbidity and mortality[J]. AnnPharmacother, 2018, 52(9):829-837. DOI: 10.1177/1060028018765159.

6.郭晓晶, 王蒙, 郭威, 等. 药品不良反应主动监测中混杂因素控制的现状及挑战[J]. 中国药物警戒, 2018, 15(10): 595-599. [Guo XJ, Wang M, Guo W, et al. Status and challenges of controlling confounding factors in active surveillance of adverse drug reactions[J]. Chinese Journal of Pharmacovigilance, 2018,15(10):595-599.] DOI: 10.3969/j.issn.1672-8629. 2018.10.004.

7.黄敬亨, 邢育健, 主编. 健康教育, 第4版[M]. 上海: 复旦大学出版社, 2008: 5-37.

8.彭静, 徐华, 刘茂昌, 等. 湖北地区儿童监护人用药安全行为风险的KAP现况[J]. 中国医院药学杂志, 2019, 39(20): 2031-2034, 2085. [Peng J, Xu H, Liu MC, et al. Investigation of KAP among guardians on the risk of drug safety behavior of child in Hubei province[J]. Chinese Journal of Hospital Pharmacy, 2019, 39(20): 2031-2034, 2085.] DOl: 10.13286/i.cnki.chinhosppharmacyj.2019.20.03.

9.杨俊丽, 张晴. 鄂尔多斯市6家医院糖尿病患者用药行为风险的知信行调查分析[J]. 药物流行病学杂志, 2023, 32(3): 263-269. [Yang JL, Zhang Q. Knowledge-attitude-practice survey on medication behavior risk of diabetic patients in 6 hospitals of Ordos city[J]. Chinese Journal of Pharmacoepidemiology, 2023, 32(3): 263-269.] DOI: 10.19960/j.issn.1005-0698.202303004.

10.孟尧尧. 滇西地区长征文化传承与发展研究[D]. 云南大理: 大理大学, 2022. DOI: 10.27811/d.cnki.gdixy.2022.000156.

11.彭波. 欠发达地区青少年健康危险行为现状与健康促进对策研究[D]. 四川南充: 西华师范大学, 2016.

12.喻娅婷, 刘丽华, 张超, 等. 湖南省居民用药行为风险KAP调查与分析[J]. 中南药学, 2018, 16(12): 1812-1816. [Yu YT, Liu LH, Zhang C, et al. KAP survey on medication behavior risk among residents in Hunan province[J]. Central South Pharmacy, 2018, 16(12): 1812-1816.] DOI: 10.7539/j.issn.1672-2981. 2018.12.037.

13.雷捷, 王胜, 王青, 等. 银川市居民安全用药现状及教育需求调查分析[J]. 药物流行病学杂志, 2019, 28(9): 594-599. [Lei J, Wang S, Wang Q, et al. Study on the current situation of safe medication and educational needs of residents in Yinchuan[J]. Chinese Journal of Pharmacoepidemiology, 2019, 28(9): 594-599.] DOI: 10.19960/j.cnki.issn1005-0698.2019.09.009.

14.秦舟, 李海霞, 田方圆, 等. 四川省居民用药行为风险知识、态度和行为调查[J]. 临床药物治疗杂志, 2019, 17(4): 73-77, 81. [Qin Z, Li HX, Tan FY, et al. Investigation and analysis of drug behavior risk KAP of residents in Sichuan province[J]. Clinical Medication Journal, 2019, 17(4): 73-77, 81.] DOI: 10.3969/i.issn.1672-3384.2019.04.017.

15.谢晓青, 宋沧桑, 包金颖, 等. 昆明市居民用药安全行为风险KAP调查研究[J]. 中国药物评价, 2021, 38(4): 355-359. [Xie XQ, Song CS, Bao JY, et al. KAP Survey on safety behavior risk of medication use among residents in Kunming city[J]. Chinese Journal of Drug Evaluation, 2021, 38(4): 355-359.] DOI: 10.3969/j.issn.2095-3593.2021.04.023.

16.王继美, 任燕, 李莉, 等. 2019年东营市居民用药风险知信行调查及影响因素研究[J]. 药物流行病学杂志, 2020, 29(9): 610-615. [Wang JM, Ren Y, Li L, et al. KAP investigation and influential factors study of medication risk among residents in Dongying area[J]. Chinese Journal of Pharmacoepidemiology, 2020, 29(9): 610-615.] DOI: 10.19960/j.cnki.issn1005-0698.2020.09.004.

17.沈娟, 刘红, 刘建军, 等. 安徽地区肿瘤患者用药安全行为风险的知识-态度-行为调查及影响因素分析[J]. 中国医院药学杂志, 2023, 43(21): 2443-2447. [Shen J, Liu H, Liu JJ, et al. Knowledge-attitude-practice survey and influencing factors analysis on drug safety behavior risk of cancer pa-tients in Anhui[J]. Chinese Journal of Hospital Pharmacy, 2023, 43(21): 2443-2447.] DOI: 10.13286/j.1001-5213.2023.21.15.

18.李春来, 姜霁航. 药师科普宣教进社区效果评价分析[J]. 世界最新医学信息文摘, 2019, 19(27): 165-166. [Li CL, Jiang JH. Evaluation and analysis of the effect of pharmacist science popularization and education in communities[J]. World Latest Medicine Information, 2019, 19(27): 165-166.] DOI: 10.19613/j.cnki.1671-3141.2019.27.104.